MSB 2.89% $1.25 mesoblast limited

Exclusion Criteria:Participants who have been a recipient of...

  1. 2,904 Posts.
    lightbulb Created with Sketch. 2057

    Exclusion Criteria:

    • Participants who have been a recipient of prior allogeneic stem cell/progenitor cell therapy for any indication or autologous stem cell/progenitor cell therapy or other biological intervention to repair the index intervertebral disc.
    • Participants with low back pain duration of less than 6 months or greater than 60 months.


    The reduction in low back pain observed in all subjects was substantially enhanced in the prespecified population with CLBP of shorter duration than the median of 68 months for the study
    (n=194)
    Reg


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.